[go: up one dir, main page]

NO20015397D0 - 1,5-Benzodiazepine derivatives - Google Patents

1,5-Benzodiazepine derivatives

Info

Publication number
NO20015397D0
NO20015397D0 NO20015397A NO20015397A NO20015397D0 NO 20015397 D0 NO20015397 D0 NO 20015397D0 NO 20015397 A NO20015397 A NO 20015397A NO 20015397 A NO20015397 A NO 20015397A NO 20015397 D0 NO20015397 D0 NO 20015397D0
Authority
NO
Norway
Prior art keywords
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
NO20015397A
Other languages
Norwegian (no)
Other versions
NO20015397L (en
Inventor
David Colclough
Anne Hodgson
Jerzy Ryszard Szewczyk
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20015397L publication Critical patent/NO20015397L/en
Publication of NO20015397D0 publication Critical patent/NO20015397D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015397A 1999-05-06 2001-11-05 1,5-Benzodiazepine derivatives NO20015397D0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process
PCT/EP2000/003982 WO2000068209A2 (en) 1999-05-06 2000-05-04 1,5-benzodiazepine derivatives as cck-a receptor agonists

Publications (2)

Publication Number Publication Date
NO20015397L NO20015397L (en) 2001-11-05
NO20015397D0 true NO20015397D0 (en) 2001-11-05

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015397A NO20015397D0 (en) 1999-05-06 2001-11-05 1,5-Benzodiazepine derivatives

Country Status (21)

Country Link
EP (1) EP1212305A2 (en)
JP (1) JP2002544200A (en)
KR (1) KR20020012567A (en)
CN (1) CN1161345C (en)
AR (1) AR022044A1 (en)
AU (1) AU4754800A (en)
BR (1) BR0010338A (en)
CA (1) CA2370801A1 (en)
CO (1) CO5170461A1 (en)
CZ (1) CZ20013988A3 (en)
HK (1) HK1046138A1 (en)
HU (1) HUP0201181A3 (en)
IL (1) IL146124A0 (en)
MX (1) MXPA01011267A (en)
MY (1) MY138319A (en)
NO (1) NO20015397D0 (en)
NZ (1) NZ515048A (en)
PE (1) PE20010110A1 (en)
PL (1) PL351546A1 (en)
TR (1) TR200103169T2 (en)
WO (1) WO2000068209A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
JP4069159B2 (en) 2004-05-25 2008-04-02 ファイザー・プロダクツ・インク Tetraazabenzo [e] azulene derivatives and analogs thereof
KR20220150270A (en) 2019-10-07 2022-11-10 칼리오페, 인크. GPR119 agonists
JP7745559B2 (en) 2020-02-28 2025-09-29 キャリーオペ，インク． GPR40 agonist

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
BR0010338A (en) 2002-02-13
NO20015397L (en) 2001-11-05
AR022044A1 (en) 2002-09-04
AU4754800A (en) 2000-11-21
CA2370801A1 (en) 2000-11-16
MY138319A (en) 2009-05-29
WO2000068209A3 (en) 2001-03-01
JP2002544200A (en) 2002-12-24
PL351546A1 (en) 2003-05-05
CZ20013988A3 (en) 2002-02-13
HUP0201181A2 (en) 2002-12-28
CO5170461A1 (en) 2002-06-27
MXPA01011267A (en) 2002-05-06
CN1362949A (en) 2002-08-07
WO2000068209A2 (en) 2000-11-16
HK1046138A1 (en) 2002-12-27
HUP0201181A3 (en) 2003-10-28
IL146124A0 (en) 2002-07-25
CN1161345C (en) 2004-08-11
EP1212305A2 (en) 2002-06-12
KR20020012567A (en) 2002-02-16
PE20010110A1 (en) 2001-03-05
TR200103169T2 (en) 2002-04-22
NZ515048A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
DE69933287D1 (en) 12,13-MODIFIED EPOTHILON DERIVATIVES
MA26831A1 (en) BENZODIAZEPINE DERIVATIVES. "
MA26832A1 (en) BENZODIAZEPINE DERIVATIVES.
TR200000520A3 (en) 4-Phenyl-pyridine derivatives.
BR0011566B1 (en) bag flexibly.
ID29241A (en) TERANELASI KINOLIN DISTRICTS-1,2
DK1000048T3 (en) Substituted 1,2,3,4-tetrahydronaphthalane derivatives
ID26743A (en) DURING 1,2,4,5-TETRAHIDRO-BENZO [D] AZEPIN
NO20010193L (en) Tiobenzimidazol derivatives
ATE236136T1 (en) BENZOSULFONE DERIVATIVES
NO20010514D0 (en) Aminometylkarboksylsyre derivatives
ATE259810T1 (en) PHENYL-XANTHINE DERIVATIVES
MA26794A1 (en) 5-PHENYL-PYRIMIDINE DERIVATIVES.
DE69821009D1 (en) 6,9-BRIDGED ERYTHROMYCIN DERIVATIVES
ATE239750T1 (en) 6,11-BRIDGED ERYTHROMYCIN DERIVATIVES
NO20003825L (en) 1,3,4 - oxadiazolone derivatives
MA26793A1 (en) 4-PHENYL-PYRIMIDINE DERIVATIVES.
DE60025958D1 (en) 14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE
DK1115716T3 (en) 2-phenylpyran-4-one derivatives
ATE233253T1 (en) CHROMEDER DERIVATIVES
DK1134219T3 (en) Cucloalkyl-substituted aminomethylpyrrolidine derivatives
DK1149106T3 (en) 4,5-azolo-oxindoles
DK1060183T3 (en) 5-deoxycytidine derivatives
PT1129079E (en) TRIAZINE DERIVATIVES 2,4-DISSUBSTITUIDOS
NO20015397D0 (en) 1,5-Benzodiazepine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application